Cas:14516-71-3 2,2′-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II) manufacturer & supplier

Chemical Name:2,2′-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II)

CAS.NO:14516-71-3

Synonyms:Phenol, 2,2′-thiobis[4-(1,1,3,3-tetramethylbutyl)-, compd. with 1-butanamine, nickel(3+) salt (1:1:1);Nickel(3+) butylazanide 2,2′-sulfanediylbis[4-(2,4,4-trimethyl-2-pentanyl)phenolate] (1:1:1);einecs 238-523-3

Molecular Formula:C₃₂H₅₀NNiO₂S

Molecular Weight:571.503

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:524.8ºC at 760 mmHg

Density:N/A

Index of Refraction:

PSA:55.79000

Exact Mass:570.291565

LogP:10.18290

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 2811 6.1/PG 3

Packing Group:

Contact us for information like Phenol, 2,2′-thiobis[4-(1,1,3,3-tetramethylbutyl)-, compd. with 1-butanamine, nickel(3+) salt (1:1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,einecs 238-523-3 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,einecs 238-523-3 Use and application,Phenol, 2,2′-thiobis[4-(1,1,3,3-tetramethylbutyl)-, compd. with 1-butanamine, nickel(3+) salt (1:1:1) technical grade,usp/ep/jp grade.

Related News: Right now, midstage data for Roche-AC Immune’s anti-tau antibody semorinemab in moderate Alzheimer’s are expected later this year, but it has already failed a phase 2 study in mild disease. 2,2′-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II) manufacturer What’s the background? 2,2′-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II) supplier The researchers found that compared with those with cancer, the prevalence of FT was higher among those with ASCVD (54 versus 41 percent). In adjusted analyses, when studying individual components of FT, those with ASCVD had increased odds of any difficulty paying medical bills, inability to pay bills, cost-related medication nonadherence, food insecurity, and foregone/delayed care due to cost (odds ratios, 1.22, 1.25, 1.28, 1.39, and 1.17, respectively). 2,2′-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II) vendor While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added. 2,2′-Thiobis(4-tert-octylphenolato)-n-butylamine nickel(II) factory While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added.